GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (OTCPK:SNZZF) » Definitions » Policy Acquisition Expense

SNZZF (Senzime AB) Policy Acquisition Expense


View and export this data going back to 2016. Start your Free Trial

What is Senzime AB Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Senzime AB Business Description

Traded in Other Exchanges
Address
Verkstadsgatan 8, Uppsala, SWE, 753 23
Senzime AB is a medical device company providing patient monitoring systems. Its portfolio comprises systems for patient monitoring of neuromuscular function and breathing, typically during and after surgery, and for the intensive care sector. TetraGraph is a system based on EMG technology for neuromuscular monitoring during surgical procedures. ExSpiron 2Xi is a non-invasive monitoring system of respiratory volume and minute ventilation used for in and out patient care. The company operates in Sweden, Germany and the USA. It derives revenue through sales of monitors and associated disposable sensors to hospitals and clinics.